200-401-191

antibody from Rockland Immunochemicals, Inc.

Targeting: RFX5

No application information provided.

Antibody Data

Product number

200-401-191

Provider

Rockland Immunochemicals, Inc.

Proper citation

Rockland Cat#200-401-191, RRID:AB_217879

Product name

Anti-RFX5 (C-terminal) (RABBIT) Antibody - 200-401-191

Antibody type

Polyclonal

Vial size

100 µl

References

Submitted references

RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4A.

Chen DB, Xie XW, Zhao YJ, Wang XY, Liao WJ, Chen P, Deng KJ, Fei R, Qin WY, Wang JH, Wu X, Shao QX, Wei L, Chen HS
Scientific reports 2020 Sep 3;10(1):14538

---

Identifying catalytic residues in CPAF, a Chlamydia-secreted protease.

Chen D, Chai J, Hart PJ, Zhong G
Archives of biochemistry and biophysics 2009 May 1;485(1):16-23

---

The RFX family interacts at the collagen (COL1A2) start site and represses transcription.

Sengupta PK, Fargo J, Smith BD
The Journal of biological chemistry 2002 Jul 12;277(28):24926-37

---

Analysis of the defect in IFN-gamma induction of MHC class II genes in G1B cells: identification of a novel and functionally critical leucine-rich motif (62-LYLYLQL-68) in the regulatory factor X 5 transcription factor.

Brickey WJ, Wright KL, Zhu XS, Ting JP
Journal of immunology (Baltimore, Md. : 1950) 1999 Dec 15;163(12):6622-30

---

The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes.

Gobin SJ, Peijnenburg A, van Eggermond M, van Zutphen M, van den Berg R, van den Elsen PJ
Immunity 1998 Oct;9(4):531-41